Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study
Severe postpartum haemorrhage (SPPH) is the leading cause of peripartum hysterectomy and maternal death. There are no easily measurable parameters that indicate the failure of medical therapy and the need for an advanced interventional procedure (AIP) to stop genital tract bleeding. The aim of the study was to define factors predictive of the need for an AIP in the management of emergent PPH.
The study included two phases: (1) an initial retrospective study of 257 consecutive patients with SPPH, allowing the determination of independent predictors of AIP, which were subsequently grouped in a predictive score, followed by (2) a multicentre study of 239 patients admitted during 2007, designed to validate the score. The main outcome measure was the need for an AIP, defined as uterine artery embolization, intraabdominal packing, arterial ligation or hysterectomy.
Abnormalities of placental implantation, prothrombin time <50% (or an International Normalized Ratio >1.64), fibrinogen <2 g/l, troponin detectable, and heart rate >115 bpm were independently predictive of the need for an AIP. The SPPH score included each of the five predictive factors with a value of 0 or 1. The greater the SPPH score, the greater the percentage of patients needing an AIP (11% for SPPH 0, to 75% for SPPH ≥2). The AUC of the ROC curve of the SPPH score was 0.80.
We identified five independent predictors of the need for an AIP in patients with SPPH and persistent bleeding. Using these predictors in a single score could be a reliable screening tool in patients at risk of persistent genital tract bleeding and needing an AIP.
KeywordsPost-partum hemorrhage Hemorrhagic shock Predictive score
- 1.World Health Organization (2009) WHO guidelines for the management of postpartum haemorrhage and retained placenta. WHO Press, Geneva. ISBN 978-92-4-159851-4Google Scholar
- 5.Subtil D, Somme A, Ardiet E, Depret-Mosser S (2004) Postpartum hemorrhage: frequency, consequences in terms of health status, and risk factors before delivery. J Gynecol Obstet Biol Reprod (Paris) 33:4S9–4S16Google Scholar
- 9.Gulmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, Abdel-Aleem H, Cheng L, Hofmeyr G, Lumbiganon P, Unger C, Prendiville W, Pinol A, Elbourne D, El-Refaey H, Schulz K (2001) WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 358:689–695PubMedCrossRefGoogle Scholar
- 10.Winter C, Macfarlane A, Deneux-Tharaux C, Zhang WH, Alexander S, Brocklehurst P, Bouvier-Colle MH, Prendiville W, Cararach V, van Roosmalen J, Berbik I, Klein M, Ayres-de-Campos D, Erkkola R, Chiechi LM, Langhoff-Roos J, Stray-Pedersen B, Troeger C (2007) Variations in policies for management of the third stage of labour and the immediate management of postpartum haemorrhage in Europe. BJOG 114:845–854PubMedCrossRefGoogle Scholar
- 12.American Society of Anesthesiologists Task Force on Obstetric Anesthesia (2007) Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia. Anesthesiology 106:843–863Google Scholar
- 16.Gissler M, Deneux-Tharaux C, Alexander S, Berg CJ, Bouvier-Colle MH, Harper M, Nannini A, Breart G, Buekens P (2007) Pregnancy-related deaths in four regions of Europe and the United States in 1999–2000: characterisation of unreported deaths. Eur J Obstet Gynecol Reprod Biol 133:179–185PubMedCrossRefGoogle Scholar
- 18.Bouvier-Colle MH, Pequignot F, Jougla E (2001) Maternal mortality in France: frequency, trends and causes. J Gynecol Obstet Biol Reprod (Paris) 30:768–775Google Scholar
- 19.Bouvier-Colle MH, Salanave B, Ancel PY, Varnoux N, Fernandez H, Papiernik E, Breart G, Benhamou D, Boutroy P, Caillier I, Dumoulin M, Fournet P, Elhassani M, Puech F, Poutot C (1996) Obstetric patients treated in intensive care units and maternal mortality. Regional Teams for the Survey. Eur J Obstet Gynecol Reprod Biol 65:121–125PubMedCrossRefGoogle Scholar
- 20.Bouvier-Colle MH, Varnoux N (2001) Maternal mortality and severe morbidity in 3 French regions: results of MOMS, a European multicenter investigation. J Gynecol Obstet Biol Reprod (Paris) 30:S5–S9Google Scholar
- 21.Bouvier-Colle MH, Varnoux N, Costes P, Hatton F (1991) Maternal mortality in France. Frequency and reasons for its under-estimation in the statistics of medical cause of death. Group of experts on maternal mortality. J Gynecol Obstet Biol Reprod (Paris) 20:885–891Google Scholar
- 28.Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB, Joseph KS, Lewis G, Liston RM, Roberts CL, Oats J, Walker J (2009) Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 9:55PubMedCrossRefGoogle Scholar